Lysophosphatidic Acid Synergizes With 1,25‐Dihydroxyvitamin D to Promote Fibroblast Growth Factor‐23 Synthesis via MAPK Signaling and Induction of the IL12A Gene
The FASEB Journal · 2026
DOI: 10.1096/fj.202502235r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Birol Ay und 7 weiteren Autor:innen. Beteiligte Einrichtung: Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Lysophospholipids, Vitamin D, Fibroblast Growth Factors, MAP Kinase Signaling System. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, HHS|NIH|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIAMS NIH HHS.
Abstract (Originalsprache)
Dysregulated actions of the bone‐derived phosphaturic hormone, fibroblast growth factor‐23 (FGF23), underlie the pathophysiology of several diseases. FGF23 is synthesized primarily in osteocytes in response to various endogenous molecules; however, the mechanisms governing FGF23 production are incompletely understood. Glycerol‐3‐phosphate (G3P), a glycolytic by‐product originating from the kidney, critically controls skeletal FGF23 synthesis via its conversion in bone to lysophosphatidic acid (LPA), which stimulates osteocyte FGF23 production. The bioactive vitamin D, 1,25‐dihydroxyvitamin D (1,25D), also promotes FGF23 production in osteocytes. We herein demonstrated that LPA requires 1,25D action to raise FGF23 levels in mouse bone explants and mice. RNA sequencing of osteocyte‐like Ocy454 cells identified differentially expressed genes (DEGs) uniquely induced by LPA/1,25D co‐treatment. These unique DEGs were enriched for the ribosome biogenesis pathway. DEGs concurrently induced by individual LPA and 1,25D treatments were enriched for MAPK signaling, and inhibiting this pathway obliterated LPA/1,25D‐induced FGF23 production. DEGs following LPA/1,25D co‐treatment were enriched for the cytokine‐cytokine receptor interaction pathway. Moreover, LPA/1,25D co‐treatment, but not individual LPA and 1,25D treatments, rapidly induced the expression of Il12a , the gene encoding the pro‐inflammatory cytokine interleukin‐12 alpha‐subunit, which responded solely to 1,25D at later times and required MAPK‐ERK1/2 signaling. Inhibiting cytokine signaling or knocking down Il12a inhibited, while overexpressing Il12a enhanced LPA/1,25D‐induced FGF23 production. However, challenging Ocy454 cells with recombinant bioactive interleukin‐12 failed to enhance FGF23 production, suggesting that Il12a plays a noncanonical role. Our results reveal a mechanism of skeletal FGF23 synthesis involving synergistic actions of LPA and 1,25D, advancing our understanding of FGF23 regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
- Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, Maryland, USA.
- Nephrology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Center for Advanced Medical Diagnostics, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
ORCID-Profile: Birol Ay, Murat Bastepe
Förderung
- NIDDK NIH HHS
- HHS|NIH|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- NIAMS NIH HHS
- NIAID NIH HHS
- NCI NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Ay, B., Cyr, S. M., Iwasaki, Y., Hill, E., Rhee, E. P., Singh, N. J., Simic, P., & Bastepe, M. (2026). Lysophosphatidic Acid Synergizes With 1,25‐Dihydroxyvitamin D to Promote Fibroblast Growth Factor‐23 Synthesis via MAPK Signaling and Induction of the IL12A Gene. The FASEB Journal. https://doi.org/10.1096/fj.202502235r
Vancouver
Ay B, Cyr SM, Iwasaki Y, Hill E, Rhee EP, Singh NJ, et al. Lysophosphatidic Acid Synergizes With 1,25‐Dihydroxyvitamin D to Promote Fibroblast Growth Factor‐23 Synthesis via MAPK Signaling and Induction of the IL12A Gene. The FASEB Journal. 2026. doi:10.1096/fj.202502235r
BibTeX
@article{Ay2026,
author = {Ay, Birol and Cyr, Sajin Marcus and Iwasaki, Yorihiro and Hill, Elizabeth and Rhee, Eugene P and Singh, Nevil J and Simic, Petra and Bastepe, Murat},
title = {Lysophosphatidic Acid Synergizes With 1,25‐Dihydroxyvitamin D to Promote Fibroblast Growth Factor‐23 Synthesis via MAPK Signaling and Induction of the IL12A Gene},
journal = {The FASEB Journal},
year = {2026},
doi = {10.1096/fj.202502235r}
}
EUVIMED